Skip to content
Login E-loket

Scientific Award AstraZeneca Foundation in New advances in diagnosis/treatment of monogenic rare diseases

Rewards innovative scientific research leading to novel insights in new advances in diagnosis/treatment of monogenic rare diseases.

Status

Budget call

In association with

Announcement of results

Objective

The AstraZeneca Foundation attaches great importance to promoting scientific research. On the initiative of the AstraZeneca Foundation, the FWO and F.R.S.-FNRS will give in 2024 a scientific award in recognition of innovative scientific research leading to novel insights in new advances in diagnosis/treatment of monogenic rare diseases.

Features

  • Prize amounting to 25,000 EURO.
  • Rewards innovative scientific research leading to novel insights in new advances in diagnosis/treatment of monogenic rare diseases.
  • The prize is intended to reward an established investigator on the basis of his/her previous work, with a perspective of future development in the same field.

Profile and conditions

  • You have a PhD.
  • The applicant must have obtained his/her first PhD degree maximum 15 years before the date of the submission deadline (possibly extended in case of eligible career breaks, see regulations).
  • The award can only be given to an individual scientist from postdoctoral level onwards who is affiliated to a Belgian university or university hospital. Prior to the submission deadline, the applicant must have held a research position in Belgium for at least five years (in a consecutive or cumulated period).

Procedure

  • Submit your candidacy using the appropriate form, filled in correctly and completely (in English), on 10 June 2024 midnight (CEST) at the latest.
  • Your candidacy is submitted to a jury.
  • The jury selects the laureate for the prize.